| Multiple introductions of SARS-CoV-2 alpha and delta variants into white-tailed deer in Pennsylvania AD Marques, S Sherrill-Mix, JK Everett, H Adhikari, S Reddy, JC Ellis, ... MBio 13 (5), e02101-22, 2022 | 39* | 2022 |
| Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries AD Marques, M Kummer, O Kondratov, A Banerjee, O Moskalenko, ... Molecular Therapy-Methods & Clinical Development 20, 276-286, 2021 | 34 | 2021 |
| Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence C Robalo-Cordeiro, P Campos, L Carvalho, A Borba, S Clemente, ... Revista Portuguesa de Pneumologia (English Edition) 23 (5), 287-293, 2017 | 25 | 2017 |
| SARS-CoV-2 Delta variant (AY. 3) in the feces of a domestic cat OC Lenz, AD Marques, BJ Kelly, KG Rodino, SD Cole, RAPM Perera, ... Viruses 14 (2), 421, 2022 | 20 | 2022 |
| Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and … H Daniell, SK Nair, H Guan, Y Guo, RJ Kulchar, MDT Torres, ... Biomaterials 288, 121671, 2022 | 19 | 2022 |
| Partial ORF1ab gene target failure with Omicron BA. 2.12. 1 KG Rodino, DR Peaper, BJ Kelly, F Bushman, A Marques, H Adhikari, ... Journal of clinical microbiology 60 (6), e00600-22, 2022 | 14 | 2022 |
| SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021 AD Marques, S Sherrill-Mix, JK Everett, S Reddy, P Hokama, AM Roche, ... MBio 13 (1), e03788-21, 2022 | 11 | 2022 |
| Multiple introductions of SARS-CoV-2 Alpha and Delta variants into white-tailed deer in Pennsylvania. mBio 13: e02101-22 AD Marques, S Sherrill-Mix, JK Everett, H Adhikari, S Reddy, JC Ellis, ... | 10 | 2022 |
| Taste receptor cells in mice express receptors for the hormone adiponectin SM Crosson, A Marques, P Dib, CD Dotson, SD Munger, S Zolotukhin Chemical Senses 44 (6), 409-422, 2019 | 10 | 2019 |
| SARS-CoV-2 evolution during prolonged infection in immunocompromised patients AD Marques, J Graham-Wooten, AS Fitzgerald, A Sobel Leonard, ... Mbio, e00110-24, 2024 | 1 | 2024 |
| Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating NS Tanneti, AK Patel, LH Tan, AD Marques, RAPM Perera, S Sherrill-Mix, ... bioRxiv, 2023 | 1 | 2023 |
| Within-Host Influenza Viral Diversity in the Pediatric Population as a Function of Age, Vaccine and Health Status AS Leonard, L Mendoza, AG McFarland, A Marques, JK Everett, L Moncla, ... Virus Evolution, veae034, 2024 | | 2024 |
| Machine Learning for Protein Engineering AD Marques Handbook of Machine Learning Applications for Genomics, 19-29, 2022 | | 2022 |
| Detection and Interspecies Comparison of SARS-CoV-2 Delta Variant (AY. 3) in Feces from a Domestic Cat and Human Samples OC Lenz, AD Marques, BJ Kelly, KG Rodino, SD Cole, RAPM Perera, ... bioRxiv, 2022 | | 2022 |
| Partial ORF1ab Gene Target Failure with Omicron BA. 2.12. 1 (preprint) KG Rodino, DR Peaper, BJ Kelly, F Bushman, A Marques, H Adhikari, ... | | 2022 |
| Evolutionary Trajectories of SARS-CoV-2 Alpha and Delta Variants in White-Tailed Deer in Pennsylvania (preprint) AD Marques, S Sherrill-Mix, J Everett, H Adhikari, S Reddy, JC Ellis, ... | | 2022 |
| Detection and Interspecies Comparison of SARS-CoV-2 Delta Variant (AY. 3) in Feces from a Domestic Cat and Human Samples (preprint) O Lenz, A Marques, B Kelly, K Rodino, S Cole, RAPM Perera, S Weiss, ... | | 2022 |
| Using machine learning to design adeno-associated virus capsids with high likelihood of viral assembly CT To, C Wirsching, AD Marques, S Zolotukhin bioRxiv, 2021.05. 18.444607, 2021 | | 2021 |
| SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021 (preprint) A Marques, S Sherrill-Mix, JK Everett, S Reddy, P Hokama, AM Roche, ... | | 2021 |
| Applying Machine Learning to Predict Viral Assembly in AAV2 Capsid Libraries AD Marques, S Zolotukhin MOLECULAR THERAPY 28 (4), 80-80, 2020 | | 2020 |
